Epigenomic Analyses Identify FOXM1 As a Key Regulator of Anti-Tumor Immune Response in Esophageal Adenocarcinoma
B. Ziman, Q. Yang, Y. Zheng, M. Sheth, C. Nam, H. Zhao, U. Sinha, D. Lin
This study identifies FOXM1 as an epigenetic regulator in EAC that suppresses anti-tumor immune responses by inhibiting CD8+ T cell infiltration and function.
bioRxiv · Jul 28, 2023Cancer Biology